‘Vaccine blood clot threat far scaled-down than Covid risks’
The conclusions of a important examine suggests that the increased challenges of blood clotting conditions from Covid vaccines is “considerably smaller” than the risks affiliated with getting the virus.
The University of Oxford-led review looked at 29 million people today who’d had their initially dose of the AstraZeneca or Pfizer vaccine.
Prof Julia Hippisley-Cox advised the BBC’s Currently programme that the “reassuring” final results “underscore the security of the vaccine and the benefits of the vaccine as opposed with getting an infection”.
The conclusions of a important examine suggests that the increased challenges of blood clotting conditions from Covid vaccines is “considerably smaller” than the risks affiliated with getting the virus.
The University of Oxford-led review looked at 29 million people today who’d had their initially dose of the AstraZeneca or Pfizer vaccine.
Prof Julia Hippisley-Cox advised the BBC’s Currently programme that the “reassuring” final results “underscore the security of the vaccine and the benefits of the vaccine as opposed with getting an infection”.
